0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Off-body Wearable Injectors Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-13W8349
Home | Market Reports | Health| Medical Devices & Equipment
Global and China Off body Wearable Injectors Market Insights Forecast to 2027
BUY CHAPTERS

Global Off-body Wearable Injectors Market Research Report 2025

Code: QYRE-Auto-13W8349
Report
September 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Off-body Wearable Injectors Market

The global market for Off-body Wearable Injectors was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Off-body Wearable Injectors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Off-body Wearable Injectors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Off-body Wearable Injectors include Becton, Dickinson and Company, Medtronic, Johnson & Johnson, Insulet Corporation, Unilife Corporation, Enable Injections, SteadyMed, Ypsomed Group, West Pharmaceutical Services, Unilife, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Off-body Wearable Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Off-body Wearable Injectors.
The Off-body Wearable Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Off-body Wearable Injectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Off-body Wearable Injectors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Off-body Wearable Injectors Market Report

Report Metric Details
Report Name Off-body Wearable Injectors Market
Segment by Type
  • Electronical Injectors
  • Mechanical Injectors
  • Others
Segment by Application
  • Immuno-oncology
  • Diabetes
  • Cardiovascular Diseases
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Becton, Dickinson and Company, Medtronic, Johnson & Johnson, Insulet Corporation, Unilife Corporation, Enable Injections, SteadyMed, Ypsomed Group, West Pharmaceutical Services, Unilife, CeQur, Sensile Medical, Roche, ScPharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Off-body Wearable Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Off-body Wearable Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Off-body Wearable Injectors Market report?

Ans: The main players in the Off-body Wearable Injectors Market are Becton, Dickinson and Company, Medtronic, Johnson & Johnson, Insulet Corporation, Unilife Corporation, Enable Injections, SteadyMed, Ypsomed Group, West Pharmaceutical Services, Unilife, CeQur, Sensile Medical, Roche, ScPharmaceuticals

What are the Application segmentation covered in the Off-body Wearable Injectors Market report?

Ans: The Applications covered in the Off-body Wearable Injectors Market report are Immuno-oncology, Diabetes, Cardiovascular Diseases, Other

What are the Type segmentation covered in the Off-body Wearable Injectors Market report?

Ans: The Types covered in the Off-body Wearable Injectors Market report are Electronical Injectors, Mechanical Injectors, Others

1 Off-body Wearable Injectors Market Overview
1.1 Product Definition
1.2 Off-body Wearable Injectors by Type
1.2.1 Global Off-body Wearable Injectors Market Value Comparison by Type (2024 VS 2031)
1.2.2 Electronical Injectors
1.2.3 Mechanical Injectors
1.2.4 Others
1.3 Off-body Wearable Injectors by Application
1.3.1 Global Off-body Wearable Injectors Market Value by Application (2024 VS 2031)
1.3.2 Immuno-oncology
1.3.3 Diabetes
1.3.4 Cardiovascular Diseases
1.3.5 Other
1.4 Global Off-body Wearable Injectors Market Size Estimates and Forecasts
1.4.1 Global Off-body Wearable Injectors Revenue 2020-2031
1.4.2 Global Off-body Wearable Injectors Sales 2020-2031
1.4.3 Global Off-body Wearable Injectors Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Off-body Wearable Injectors Market Competition by Manufacturers
2.1 Global Off-body Wearable Injectors Sales Market Share by Manufacturers (2020-2025)
2.2 Global Off-body Wearable Injectors Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Off-body Wearable Injectors Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Off-body Wearable Injectors, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Off-body Wearable Injectors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Off-body Wearable Injectors, Product Type & Application
2.7 Global Key Manufacturers of Off-body Wearable Injectors, Date of Enter into This Industry
2.8 Global Off-body Wearable Injectors Market Competitive Situation and Trends
2.8.1 Global Off-body Wearable Injectors Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Off-body Wearable Injectors Players Market Share by Revenue
2.8.3 Global Off-body Wearable Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Off-body Wearable Injectors Market Scenario by Region
3.1 Global Off-body Wearable Injectors Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Off-body Wearable Injectors Sales by Region: 2020-2031
3.2.1 Global Off-body Wearable Injectors Sales by Region: 2020-2025
3.2.2 Global Off-body Wearable Injectors Sales by Region: 2026-2031
3.3 Global Off-body Wearable Injectors Revenue by Region: 2020-2031
3.3.1 Global Off-body Wearable Injectors Revenue by Region: 2020-2025
3.3.2 Global Off-body Wearable Injectors Revenue by Region: 2026-2031
3.4 North America Off-body Wearable Injectors Market Facts & Figures by Country
3.4.1 North America Off-body Wearable Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Off-body Wearable Injectors Sales by Country (2020-2031)
3.4.3 North America Off-body Wearable Injectors Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Off-body Wearable Injectors Market Facts & Figures by Country
3.5.1 Europe Off-body Wearable Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Off-body Wearable Injectors Sales by Country (2020-2031)
3.5.3 Europe Off-body Wearable Injectors Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Off-body Wearable Injectors Market Facts & Figures by Region
3.6.1 Asia Pacific Off-body Wearable Injectors Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Off-body Wearable Injectors Sales by Region (2020-2031)
3.6.3 Asia Pacific Off-body Wearable Injectors Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Off-body Wearable Injectors Market Facts & Figures by Country
3.7.1 Latin America Off-body Wearable Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Off-body Wearable Injectors Sales by Country (2020-2031)
3.7.3 Latin America Off-body Wearable Injectors Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Off-body Wearable Injectors Market Facts & Figures by Country
3.8.1 Middle East and Africa Off-body Wearable Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Off-body Wearable Injectors Sales by Country (2020-2031)
3.8.3 Middle East and Africa Off-body Wearable Injectors Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Off-body Wearable Injectors Sales by Type (2020-2031)
4.1.1 Global Off-body Wearable Injectors Sales by Type (2020-2025)
4.1.2 Global Off-body Wearable Injectors Sales by Type (2026-2031)
4.1.3 Global Off-body Wearable Injectors Sales Market Share by Type (2020-2031)
4.2 Global Off-body Wearable Injectors Revenue by Type (2020-2031)
4.2.1 Global Off-body Wearable Injectors Revenue by Type (2020-2025)
4.2.2 Global Off-body Wearable Injectors Revenue by Type (2026-2031)
4.2.3 Global Off-body Wearable Injectors Revenue Market Share by Type (2020-2031)
4.3 Global Off-body Wearable Injectors Price by Type (2020-2031)
5 Segment by Application
5.1 Global Off-body Wearable Injectors Sales by Application (2020-2031)
5.1.1 Global Off-body Wearable Injectors Sales by Application (2020-2025)
5.1.2 Global Off-body Wearable Injectors Sales by Application (2026-2031)
5.1.3 Global Off-body Wearable Injectors Sales Market Share by Application (2020-2031)
5.2 Global Off-body Wearable Injectors Revenue by Application (2020-2031)
5.2.1 Global Off-body Wearable Injectors Revenue by Application (2020-2025)
5.2.2 Global Off-body Wearable Injectors Revenue by Application (2026-2031)
5.2.3 Global Off-body Wearable Injectors Revenue Market Share by Application (2020-2031)
5.3 Global Off-body Wearable Injectors Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Becton, Dickinson and Company
6.1.1 Becton, Dickinson and Company Company Information
6.1.2 Becton, Dickinson and Company Description and Business Overview
6.1.3 Becton, Dickinson and Company Off-body Wearable Injectors Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Becton, Dickinson and Company Off-body Wearable Injectors Product Portfolio
6.1.5 Becton, Dickinson and Company Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Company Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Off-body Wearable Injectors Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Medtronic Off-body Wearable Injectors Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Company Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Off-body Wearable Injectors Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Johnson & Johnson Off-body Wearable Injectors Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Insulet Corporation
6.4.1 Insulet Corporation Company Information
6.4.2 Insulet Corporation Description and Business Overview
6.4.3 Insulet Corporation Off-body Wearable Injectors Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Insulet Corporation Off-body Wearable Injectors Product Portfolio
6.4.5 Insulet Corporation Recent Developments/Updates
6.5 Unilife Corporation
6.5.1 Unilife Corporation Company Information
6.5.2 Unilife Corporation Description and Business Overview
6.5.3 Unilife Corporation Off-body Wearable Injectors Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Unilife Corporation Off-body Wearable Injectors Product Portfolio
6.5.5 Unilife Corporation Recent Developments/Updates
6.6 Enable Injections
6.6.1 Enable Injections Company Information
6.6.2 Enable Injections Description and Business Overview
6.6.3 Enable Injections Off-body Wearable Injectors Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Enable Injections Off-body Wearable Injectors Product Portfolio
6.6.5 Enable Injections Recent Developments/Updates
6.7 SteadyMed
6.7.1 SteadyMed Company Information
6.7.2 SteadyMed Description and Business Overview
6.7.3 SteadyMed Off-body Wearable Injectors Sales, Revenue and Gross Margin (2020-2025)
6.7.4 SteadyMed Off-body Wearable Injectors Product Portfolio
6.7.5 SteadyMed Recent Developments/Updates
6.8 Ypsomed Group
6.8.1 Ypsomed Group Company Information
6.8.2 Ypsomed Group Description and Business Overview
6.8.3 Ypsomed Group Off-body Wearable Injectors Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Ypsomed Group Off-body Wearable Injectors Product Portfolio
6.8.5 Ypsomed Group Recent Developments/Updates
6.9 West Pharmaceutical Services
6.9.1 West Pharmaceutical Services Company Information
6.9.2 West Pharmaceutical Services Description and Business Overview
6.9.3 West Pharmaceutical Services Off-body Wearable Injectors Sales, Revenue and Gross Margin (2020-2025)
6.9.4 West Pharmaceutical Services Off-body Wearable Injectors Product Portfolio
6.9.5 West Pharmaceutical Services Recent Developments/Updates
6.10 Unilife
6.10.1 Unilife Company Information
6.10.2 Unilife Description and Business Overview
6.10.3 Unilife Off-body Wearable Injectors Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Unilife Off-body Wearable Injectors Product Portfolio
6.10.5 Unilife Recent Developments/Updates
6.11 CeQur
6.11.1 CeQur Company Information
6.11.2 CeQur Description and Business Overview
6.11.3 CeQur Off-body Wearable Injectors Sales, Revenue and Gross Margin (2020-2025)
6.11.4 CeQur Off-body Wearable Injectors Product Portfolio
6.11.5 CeQur Recent Developments/Updates
6.12 Sensile Medical
6.12.1 Sensile Medical Company Information
6.12.2 Sensile Medical Description and Business Overview
6.12.3 Sensile Medical Off-body Wearable Injectors Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sensile Medical Off-body Wearable Injectors Product Portfolio
6.12.5 Sensile Medical Recent Developments/Updates
6.13 Roche
6.13.1 Roche Company Information
6.13.2 Roche Description and Business Overview
6.13.3 Roche Off-body Wearable Injectors Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Roche Off-body Wearable Injectors Product Portfolio
6.13.5 Roche Recent Developments/Updates
6.14 ScPharmaceuticals
6.14.1 ScPharmaceuticals Company Information
6.14.2 ScPharmaceuticals Description and Business Overview
6.14.3 ScPharmaceuticals Off-body Wearable Injectors Sales, Revenue and Gross Margin (2020-2025)
6.14.4 ScPharmaceuticals Off-body Wearable Injectors Product Portfolio
6.14.5 ScPharmaceuticals Recent Developments/Updates
6.15 SteadyMed
6.15.1 SteadyMed Company Information
6.15.2 SteadyMed Description and Business Overview
6.15.3 SteadyMed Off-body Wearable Injectors Sales, Revenue and Gross Margin (2020-2025)
6.15.4 SteadyMed Off-body Wearable Injectors Product Portfolio
6.15.5 SteadyMed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Off-body Wearable Injectors Industry Chain Analysis
7.2 Off-body Wearable Injectors Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Off-body Wearable Injectors Production Mode & Process Analysis
7.4 Off-body Wearable Injectors Sales and Marketing
7.4.1 Off-body Wearable Injectors Sales Channels
7.4.2 Off-body Wearable Injectors Distributors
7.5 Off-body Wearable Injectors Customer Analysis
8 Off-body Wearable Injectors Market Dynamics
8.1 Off-body Wearable Injectors Industry Trends
8.2 Off-body Wearable Injectors Market Drivers
8.3 Off-body Wearable Injectors Market Challenges
8.4 Off-body Wearable Injectors Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Off-body Wearable Injectors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Off-body Wearable Injectors Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Off-body Wearable Injectors Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Off-body Wearable Injectors Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Off-body Wearable Injectors Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Off-body Wearable Injectors Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Off-body Wearable Injectors Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Off-body Wearable Injectors Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Off-body Wearable Injectors, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Off-body Wearable Injectors, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Off-body Wearable Injectors, Product Type & Application
 Table 12. Global Key Manufacturers of Off-body Wearable Injectors, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Off-body Wearable Injectors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Off-body Wearable Injectors as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Off-body Wearable Injectors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Off-body Wearable Injectors Sales by Region (2020-2025) & (K Units)
 Table 18. Global Off-body Wearable Injectors Sales Market Share by Region (2020-2025)
 Table 19. Global Off-body Wearable Injectors Sales by Region (2026-2031) & (K Units)
 Table 20. Global Off-body Wearable Injectors Sales Market Share by Region (2026-2031)
 Table 21. Global Off-body Wearable Injectors Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Off-body Wearable Injectors Revenue Market Share by Region (2020-2025)
 Table 23. Global Off-body Wearable Injectors Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Off-body Wearable Injectors Revenue Market Share by Region (2026-2031)
 Table 25. North America Off-body Wearable Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Off-body Wearable Injectors Sales by Country (2020-2025) & (K Units)
 Table 27. North America Off-body Wearable Injectors Sales by Country (2026-2031) & (K Units)
 Table 28. North America Off-body Wearable Injectors Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Off-body Wearable Injectors Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Off-body Wearable Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Off-body Wearable Injectors Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Off-body Wearable Injectors Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Off-body Wearable Injectors Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Off-body Wearable Injectors Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Off-body Wearable Injectors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Off-body Wearable Injectors Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Off-body Wearable Injectors Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Off-body Wearable Injectors Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Off-body Wearable Injectors Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Off-body Wearable Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Off-body Wearable Injectors Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Off-body Wearable Injectors Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Off-body Wearable Injectors Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Off-body Wearable Injectors Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Off-body Wearable Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Off-body Wearable Injectors Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Off-body Wearable Injectors Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Off-body Wearable Injectors Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Off-body Wearable Injectors Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Off-body Wearable Injectors Sales (K Units) by Type (2020-2025)
 Table 51. Global Off-body Wearable Injectors Sales (K Units) by Type (2026-2031)
 Table 52. Global Off-body Wearable Injectors Sales Market Share by Type (2020-2025)
 Table 53. Global Off-body Wearable Injectors Sales Market Share by Type (2026-2031)
 Table 54. Global Off-body Wearable Injectors Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Off-body Wearable Injectors Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Off-body Wearable Injectors Revenue Market Share by Type (2020-2025)
 Table 57. Global Off-body Wearable Injectors Revenue Market Share by Type (2026-2031)
 Table 58. Global Off-body Wearable Injectors Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Off-body Wearable Injectors Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Off-body Wearable Injectors Sales (K Units) by Application (2020-2025)
 Table 61. Global Off-body Wearable Injectors Sales (K Units) by Application (2026-2031)
 Table 62. Global Off-body Wearable Injectors Sales Market Share by Application (2020-2025)
 Table 63. Global Off-body Wearable Injectors Sales Market Share by Application (2026-2031)
 Table 64. Global Off-body Wearable Injectors Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Off-body Wearable Injectors Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Off-body Wearable Injectors Revenue Market Share by Application (2020-2025)
 Table 67. Global Off-body Wearable Injectors Revenue Market Share by Application (2026-2031)
 Table 68. Global Off-body Wearable Injectors Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Off-body Wearable Injectors Price (US$/Unit) by Application (2026-2031)
 Table 70. Becton, Dickinson and Company Company Information
 Table 71. Becton, Dickinson and Company Description and Business Overview
 Table 72. Becton, Dickinson and Company Off-body Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Becton, Dickinson and Company Off-body Wearable Injectors Product
 Table 74. Becton, Dickinson and Company Recent Developments/Updates
 Table 75. Medtronic Company Information
 Table 76. Medtronic Description and Business Overview
 Table 77. Medtronic Off-body Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Medtronic Off-body Wearable Injectors Product
 Table 79. Medtronic Recent Developments/Updates
 Table 80. Johnson & Johnson Company Information
 Table 81. Johnson & Johnson Description and Business Overview
 Table 82. Johnson & Johnson Off-body Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Johnson & Johnson Off-body Wearable Injectors Product
 Table 84. Johnson & Johnson Recent Developments/Updates
 Table 85. Insulet Corporation Company Information
 Table 86. Insulet Corporation Description and Business Overview
 Table 87. Insulet Corporation Off-body Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Insulet Corporation Off-body Wearable Injectors Product
 Table 89. Insulet Corporation Recent Developments/Updates
 Table 90. Unilife Corporation Company Information
 Table 91. Unilife Corporation Description and Business Overview
 Table 92. Unilife Corporation Off-body Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Unilife Corporation Off-body Wearable Injectors Product
 Table 94. Unilife Corporation Recent Developments/Updates
 Table 95. Enable Injections Company Information
 Table 96. Enable Injections Description and Business Overview
 Table 97. Enable Injections Off-body Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Enable Injections Off-body Wearable Injectors Product
 Table 99. Enable Injections Recent Developments/Updates
 Table 100. SteadyMed Company Information
 Table 101. SteadyMed Description and Business Overview
 Table 102. SteadyMed Off-body Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. SteadyMed Off-body Wearable Injectors Product
 Table 104. SteadyMed Recent Developments/Updates
 Table 105. Ypsomed Group Company Information
 Table 106. Ypsomed Group Description and Business Overview
 Table 107. Ypsomed Group Off-body Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Ypsomed Group Off-body Wearable Injectors Product
 Table 109. Ypsomed Group Recent Developments/Updates
 Table 110. West Pharmaceutical Services Company Information
 Table 111. West Pharmaceutical Services Description and Business Overview
 Table 112. West Pharmaceutical Services Off-body Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. West Pharmaceutical Services Off-body Wearable Injectors Product
 Table 114. West Pharmaceutical Services Recent Developments/Updates
 Table 115. Unilife Company Information
 Table 116. Unilife Description and Business Overview
 Table 117. Unilife Off-body Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Unilife Off-body Wearable Injectors Product
 Table 119. Unilife Recent Developments/Updates
 Table 120. CeQur Company Information
 Table 121. CeQur Description and Business Overview
 Table 122. CeQur Off-body Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. CeQur Off-body Wearable Injectors Product
 Table 124. CeQur Recent Developments/Updates
 Table 125. Sensile Medical Company Information
 Table 126. Sensile Medical Description and Business Overview
 Table 127. Sensile Medical Off-body Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Sensile Medical Off-body Wearable Injectors Product
 Table 129. Sensile Medical Recent Developments/Updates
 Table 130. Roche Company Information
 Table 131. Roche Description and Business Overview
 Table 132. Roche Off-body Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Roche Off-body Wearable Injectors Product
 Table 134. Roche Recent Developments/Updates
 Table 135. ScPharmaceuticals Company Information
 Table 136. ScPharmaceuticals Description and Business Overview
 Table 137. ScPharmaceuticals Off-body Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. ScPharmaceuticals Off-body Wearable Injectors Product
 Table 139. ScPharmaceuticals Recent Developments/Updates
 Table 140. SteadyMed Company Information
 Table 141. SteadyMed Description and Business Overview
 Table 142. SteadyMed Off-body Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. SteadyMed Off-body Wearable Injectors Product
 Table 144. SteadyMed Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Off-body Wearable Injectors Distributors List
 Table 148. Off-body Wearable Injectors Customers List
 Table 149. Off-body Wearable Injectors Market Trends
 Table 150. Off-body Wearable Injectors Market Drivers
 Table 151. Off-body Wearable Injectors Market Challenges
 Table 152. Off-body Wearable Injectors Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Off-body Wearable Injectors
 Figure 2. Global Off-body Wearable Injectors Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Off-body Wearable Injectors Market Share by Type: 2024 & 2031
 Figure 4. Electronical Injectors Product Picture
 Figure 5. Mechanical Injectors Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Off-body Wearable Injectors Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Off-body Wearable Injectors Market Share by Application: 2024 & 2031
 Figure 9. Immuno-oncology
 Figure 10. Diabetes
 Figure 11. Cardiovascular Diseases
 Figure 12. Other
 Figure 13. Global Off-body Wearable Injectors Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Off-body Wearable Injectors Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Off-body Wearable Injectors Sales (2020-2031) & (K Units)
 Figure 16. Global Off-body Wearable Injectors Average Price (US$/Unit) & (2020-2031)
 Figure 17. Off-body Wearable Injectors Report Years Considered
 Figure 18. Off-body Wearable Injectors Sales Share by Manufacturers in 2024
 Figure 19. Global Off-body Wearable Injectors Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Off-body Wearable Injectors Players: Market Share by Revenue in Off-body Wearable Injectors in 2024
 Figure 21. Off-body Wearable Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Off-body Wearable Injectors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Off-body Wearable Injectors Sales Market Share by Country (2020-2031)
 Figure 24. North America Off-body Wearable Injectors Revenue Market Share by Country (2020-2031)
 Figure 25. United States Off-body Wearable Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Off-body Wearable Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Off-body Wearable Injectors Sales Market Share by Country (2020-2031)
 Figure 28. Europe Off-body Wearable Injectors Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Off-body Wearable Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Off-body Wearable Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Off-body Wearable Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Off-body Wearable Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Off-body Wearable Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Off-body Wearable Injectors Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Off-body Wearable Injectors Revenue Market Share by Region (2020-2031)
 Figure 36. China Off-body Wearable Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Off-body Wearable Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Off-body Wearable Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Off-body Wearable Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Off-body Wearable Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Off-body Wearable Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Off-body Wearable Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Off-body Wearable Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Off-body Wearable Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Off-body Wearable Injectors Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Off-body Wearable Injectors Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Off-body Wearable Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Off-body Wearable Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Off-body Wearable Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Off-body Wearable Injectors Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Off-body Wearable Injectors Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Off-body Wearable Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Off-body Wearable Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Off-body Wearable Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Off-body Wearable Injectors by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Off-body Wearable Injectors by Type (2020-2031)
 Figure 57. Global Off-body Wearable Injectors Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Off-body Wearable Injectors by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Off-body Wearable Injectors by Application (2020-2031)
 Figure 60. Global Off-body Wearable Injectors Price (US$/Unit) by Application (2020-2031)
 Figure 61. Off-body Wearable Injectors Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart